Both in Pharmaceuticals
Actuate Therapeutics vs Moleculin Biotech
Over the past year ACTU returned −94.8% and MBRX returned −96.8%; their daily moves had a correlation of -0.05.
ACTU −94.8% MBRX −96.8%Growth of $1, one year, split-adjusted
| Metric | ACTU | MBRX |
|---|---|---|
| Price | $0.3500 | $8.30 |
| Market cap | $8.4M | $8.5M |
| Today | +2.34% | −0.24% |
| 1 month | −60.0% | −12.9% |
| 6 months | −88.6% | −83.3% |
| Year to date | −94.3% | −87.5% |
| 1 year | −94.7% | −96.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 161.0% | 850.7% |
| Short % of float | 19.2% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).